Display options
Cite
Labiris G, Ntonti P, Sideroudi H, et al. Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study. Eye Vis (Lond). 2017;4:13doi: 10.1186/s40662-017-0079-5.
Labiris, G., Ntonti, P., Sideroudi, H., & Kozobolis, V. (2017). Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study. Eye and vision (London, England), 413. https://doi.org/10.1186/s40662-017-0079-5
Labiris, Georgios, et al. "Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study." Eye and vision (London, England) vol. 4 (2017): 13. doi: https://doi.org/10.1186/s40662-017-0079-5
Labiris G, Ntonti P, Sideroudi H, Kozobolis V. Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study. Eye Vis (Lond). 2017 May 10;4:13. doi: 10.1186/s40662-017-0079-5. eCollection 2017. PMID: 28497070; PMCID: PMC5424421.
Copy Download .nbib Format: NLM
Share it on

Eye Vis (Lond). 2017 May 10;4:13. doi: 10.1186/s40662-017-0079-5. eCollection 2017.

Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study.

Eye and vision (London, England)

Georgios Labiris, Panagiota Ntonti, Haris Sideroudi, Vassilios Kozobolis

Affiliations

  1. Department of Ophthalmology, University Hospital of Alexandroupolis, 68100 Dragana, Alexandroupolis, Greece.
  2. Eye Institute of Thrace, Alexandroupolis, Greece.

PMID: 28497070 PMCID: PMC5424421 DOI: 10.1186/s40662-017-0079-5

Abstract

BACKGROUND: Universal postoperative guidelines for cataract extraction surgery are yet to be introduced. Artificial tears are gaining popularity as an additional integral component of the postoperative regime. The primary objective of this study was to explore the impact of two prevalent artificial tear preparations on postoperative discomfort following cataract extraction surgery.

METHODS: A total of 180 patients that underwent cataract extraction surgery were randomly divided into three groups according to their postoperative regime: a) Study group 1 (SG1) received a fixed combination of tobramycin and dexamethasone (FCTD) quid for 3 weeks and, additionally polyethylene glycol 400/propylene glycol/hydroxypropyl-guar quid, for 6 weeks, b) Study group 2 (SG2) received FCTD quid for 3 weeks and, additionally 0.1% sodium hyaluronate provided in the COMOD® device quid, for 6 weeks, and, c) Control Group (CG) received only FCTD quid for 3 weeks. The following indexes were evaluated at three postoperative checkpoints: 1) Subjective discomfort index (SDI) derived from four direct 10-scale Likert-type questions that were addressed to the patient and pertained to: a) foreign body sensation (FBS), b) blinking discomfort (BD), c) stinging sensation (SS), d) tearing sensation (TS), 2) Tear break-up time (TBUT), 3) Central corneal thickness (CCT) and, 4) Central Corneal Sensitivity (CCS).

RESULTS: Both groups showed increased CCT values at the first examination point and reduced CCS values at all examination points. Furthermore, both SGs had better TBUT times at all examination points compared to CG (CG: 8.86 ± 1.08, SG1: 9.59 ± 1.45, CG2: 9.45 ± 1.33,

CONCLUSION: Polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate provided in the COMOD® device seem to be equally efficient in alleviating OSD symptoms following cataract extraction surgery and any of them should be routinely added to the postoperative regime.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: https://clinicaltrials.gov/ct2/show/NCT02558218NCT02558218.

Keywords: Artificial tears; Cataract; Hylocomod; Postoperative regimen; Surface discomfort index; Systane

References

  1. Br J Ophthalmol. 2012 May;96(5):614-8 - PubMed
  2. Cornea. 2007 Oct;26(9 Suppl 1):S16-20 - PubMed
  3. J Cataract Refract Surg. 2015 Mar;41(3):681-2 - PubMed
  4. Cont Lens Anterior Eye. 2010 Apr;33(2):93-9 - PubMed
  5. J Ocul Pharmacol Ther. 2008 Dec;24(6):593-9 - PubMed
  6. Arch Ophthalmol. 2006 Sep;124(9):1308-14 - PubMed
  7. Curr Opin Ophthalmol. 2015 Jan;26(1):45-9 - PubMed
  8. Ophthalmology. 2015 Nov;122(11):2159-68 - PubMed
  9. Eye (Lond). 2010 Aug;24(8):1331-7 - PubMed
  10. Cornea. 2006 Sep;25(8):900-7 - PubMed
  11. Cochrane Database Syst Rev. 2016 Jul 08;7:CD010735 - PubMed
  12. Curr Med Res Opin. 2011 Sep;27(9):1693-703 - PubMed
  13. Ophthalmology. 2013 Dec;120(12):2367-76 - PubMed
  14. PLoS One. 2016 Jan 15;11(1):e0146752 - PubMed
  15. Ophthalmic Res. 2013;49(1):37-42 - PubMed
  16. Curr Opin Ophthalmol. 2016 Jan;27(1):24-30 - PubMed
  17. J Cataract Refract Surg. 2013 Sep;39(9):1421-31 - PubMed
  18. PLoS One. 2013 Nov 12;8(11):e78657 - PubMed
  19. J Cataract Refract Surg. 2007 Feb;33(2):287-92 - PubMed
  20. Int J Ophthalmol. 2016 Feb 18;9(2):306-11 - PubMed
  21. Cornea. 2008 Aug;27(7):855 - PubMed
  22. Graefes Arch Clin Exp Ophthalmol. 2012 Sep;250(9):1333-40 - PubMed
  23. J Cataract Refract Surg. 2015 Jan;41(1):53-7 - PubMed
  24. J Cataract Refract Surg. 2015 Aug;41(8):1699-704 - PubMed
  25. Curr Opin Ophthalmol. 2017 Jan;27 Suppl 1:3-47 - PubMed
  26. Drug Chem Toxicol. 2016 Oct;39(4):455-60 - PubMed
  27. Eur J Ophthalmol. 2007 Sep-Oct;17(5):733-42 - PubMed
  28. Curr Eye Res. 2004 Jan;28(1):55-62 - PubMed
  29. Clin Ophthalmol. 2011;5:783-90 - PubMed
  30. Cornea. 2008 Sep;27 Suppl 1:S13-8 - PubMed
  31. Clin Ophthalmol. 2012;6:1113-24 - PubMed

Publication Types